Motohiro Murakami, Hitoshi Ishikawa, Yuta Sekino, Hiroyuki Nishiyama, Hiroyoshi Suzuki, Shinji Sugahara, Takashi Iizumi, Masashi Mizumoto, Toshiyuki Okumura, Naoto Keino, Yuichi Iizumi, Koichi Hashimoto, Masahiko Gosho, Hideyuki Sakurai
The usefulness of moderately hypofractionated radiotherapy for localized prostate cancer has been extensively reported, but there are limited studies on proton beam therapy (PBT) using similar hypofractionation schedules. The aim of this prospective phase II study is to confirm the safety of a shortened PBT course using 70 Gy relative biological effectiveness (RBE) in 28 fractions. From May 2013 to June 2015, 102 men with localized prostate cancer were enrolled. Androgen deprivation therapy was administered according to risk classification...
May 12, 2024: Journal of Radiation Research